Research & KnowledgeEvent: September 8, 2026
CubicBio published a 2026 older-human cohort study showing short-term rapamycin treatment altered immune and inflammatory markers but failed to reset the epigenetic biological clock.
Published
Signal category
Research & Knowledge
Quote
“In a 2026 older-human cohort study, short-term rapamycin treatment altered immune and inflammatory markers but failed to reset the epigenetic biological clock.”
— Ramon Coronado Schmilinski M.S., Ph.D.|CubicBio team
Company
- Industry
- Biotechnology Research
- Company size
- 2 employees